Detailed Explanation
Blinding, also called masking, is a methodological technique designed to minimize bias in clinical trial results by preventing knowledge of treatment assignments from influencing behavior or assessments. When successful, blinding ensures that expectations about treatment effects do not consciously or unconsciously affect how participants report symptoms, how investigators evaluate outcomes, or how data analysts interpret results. This protection against bias is essential for generating credible evidence about treatment effects.